Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review
Robert Foerster(University of Zurich), Vedang Murthy(Homi Bhabha National Institute), Erwin Vu(University of St.Gallen), Sati Akbaba(Johannes Gutenberg University Mainz), André Buchali(Medizinische Hochschule Brandenburg Theodor Fontane), Tilman Bostel(Johannes Gutenberg University Mainz), Daniel R. Zwahlen(Kantonsspital Winterthur), Tanja Sprave(University Medical Center Freiburg), Paul Windisch(Kantonsspital Winterthur), Constantinos Zamboglou(University Hospitals of Cleveland), Hongjian Tang(Kantonsspital Winterthur), Jean‐Jacques Stelmes(European Organisation for Research and Treatment of Cancer), Tejshri Telkhade(Tata Memorial Hospital), Christina Schroeder(Paul Scherrer Institute), Thomas Zilli(University of Geneva)
Cited by 42
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377